Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Understanding pulmonary arterial hypertension.

Susan Simmons Holcomb1

  • 1Walk-In Health Care of Olathe, KS, USA.

Nursing Management
|May 10, 2005
PubMed
Summary

New therapies are enhancing the management of pulmonary arterial hypertension (PAH). These advancements offer improved treatment options for patients suffering from this serious lung condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Get an earful of the new cerumen impaction guidelines.

The Nurse practitioner·2010
Same author

Hormone therapy for menopausal women.

The Nurse practitioner·2009
Same author

Thyroid storm.

Nursing·2009
Same author

Pediatric heatstroke.

Nursing·2009
Same author

Infective endocarditis prophylaxis.

The Nurse practitioner·2009
Same author

Common herb-drug interactions: what you should know.

The Nurse practitioner·2009

Area of Science:

  • Cardiology
  • Pulmonology
  • Pharmacology

Background:

  • Pulmonary arterial hypertension (PAH) is a progressive disease characterized by high blood pressure in the lung arteries.
  • PAH leads to right heart failure and reduced quality of life.
  • Current management strategies aim to alleviate symptoms and slow disease progression.

Purpose of the Study:

  • To review recent advancements in the therapeutic management of pulmonary arterial hypertension.
  • To highlight novel drug targets and treatment modalities.
  • To assess the impact of new therapies on patient outcomes.

Main Methods:

  • Systematic literature review of clinical trials and observational studies.
  • Analysis of pharmacological data for newly approved and investigational drugs.
  • Evaluation of treatment guidelines and expert consensus.

Main Results:

  • Several new therapeutic agents targeting distinct pathways have shown significant efficacy.
  • Combination therapy approaches demonstrate improved hemodynamic and clinical outcomes.
  • Non-pharmacological interventions are being refined for better patient support.

Conclusions:

  • Recent therapeutic innovations have substantially improved the management of pulmonary arterial hypertension.
  • Early diagnosis and tailored treatment strategies are crucial for optimal patient care.
  • Ongoing research promises further improvements in long-term outcomes for PAH patients.

Related Experiment Videos